Since currently available antipsychotic medications predominantly treat hallucinations,
delusions, disorganized thoughts and behavior, and related agitation/aggression, attention …

Brain-Derived Neurotrophic Factor (BDNF) is a neurotrophin that has been related not only
to neurodevelopment and neuroprotection, but also to synapse regulation, learning, and …

This well-established and accessible text has been completely revised in this expanded fifth
edition. Each chapter has been updated, often extensively, to reflect current thinking, and an …

Expertly collected, well-curated data sets consisting of comprehensive clinical
characterization and raw structural, functional and diffusion-weighted DICOM images in …

Negative symptoms (NS), conceived as Avolition-Apathy (AA) and Expressive Deficit (EXP)
domains, and neurocognitive impairments represent unmet therapeutic needs for patients …

Cognitive impairment is a core feature of schizophrenia but there is limited understanding of
the genetic relationship between cognition in the general population and schizophrenia. We …

In light of the number of studies conducted to examine the treatment of cognitive impairment
associated with schizophrenia (CIAS), we critically reviewed recent CIAS trials. Trials were …

Previous studies have found varying relationships between cognitive functioning and brain
volumes in patients with schizophrenia. However, cortical thickness may more closely reflect …

Different regions of the cortex have been implicated in the pathophysiology of
schizophrenia. Recently published data suggested there are many more changes in gene …

Schizophrenia (SZ) is a debilitating neurodevelopmental disorder that strikes at a critical
period of a young person's life. Its pathophysiology could be the result of deregulation of …